Related Experiment Videos
Pacing Therapies in Congestive Heart Failure II study
C Stellbrink1, A Auricchio, C Butter
1University Hospital RWTH, Aachen, Germany.
The American Journal of Cardiology
|November 21, 2000
Summary
Ventricular resynchronization therapy (VRT) improves heart failure outcomes. This study investigates optimized univentricular pacing, assessing both immediate hemodynamic and long-term functional effects in advanced heart failure patients.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Ventricular resynchronization therapy (VRT) is an emerging treatment for advanced heart failure with conduction disturbances.
- Limited long-term data and unanswered questions regarding optimal VRT strategies exist.
Purpose of the Study:
- To investigate the potential benefits of optimized univentricular pacing in patients with advanced heart failure.
- To assess acute hemodynamic and chronic functional effects of VRT.
Main Methods:
- Prospective, randomized, cross-over study (PATH-CHF II) in 64 advanced heart failure patients.
- Evaluation of different left ventricular pacing sites, alone or with right ventricular pacing.
- Assessment of functional capacity (exercise testing, 6-minute walk), quality of life, and NYHA class.
Main Results:
- Acute hemodynamic testing focused on optimizing pacing sites for improved performance.
- Primary endpoint: improvement in functional capacity.
- Secondary endpoints: enhanced quality of life and reduced hospitalizations.
Conclusions:
- Optimized univentricular pacing shows potential for improving functional capacity and quality of life in heart failure patients.
- Further research is needed to define optimal VRT strategies and patient selection criteria.